Key facts
- It has raised $830K; the latest was Seed Round ($830K) in Jan 2025.
- Notable investors include StartLife, Oost NL, Rijksdienst voor Ondernemend Nederland, AtlasInvest Entrepreneurship Grant, Capricorn Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for InsectSense
- ·The full record, as it builds
Funding rounds
No funding rounds for InsectSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InsectSense
Operator of a biotechnology firm intended to develop disruptive innovations inspired by insects that create positive societal and environmental impact around the world. The company helps to solve global challenges by exploring the limitless potential of insects and valorizing their capabilities, enabling physicians to determine the fingerprint of the volatile compounds from a complex mixture of samples to diagnose novel diseases accurately and precisely.
- Sector
- Healthcare
- HQ
- Wageningen, Netherlands
- Founded
- 2020
- Employees
- 8
- Website
- insectsense.com/
- Ownership
- Privately Held (backing)
InsectSense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InsectSense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InsectSense in its N-PORT filings yet. We sweep new filings monthly.